Criteria
Leader criteria
Sector
Communication Services
12
Consumer Discretionary
49
Consumer Staples
35
Energy
19
Financials
64
Health Care
57
Industrials
95
Information Technology
87
Materials
25
Real Estate
29
Utilities
31
S&P 500
| Ticker ▼ | Company | Index | Sector | Price | 1wk | 1mo | 1yr | ATR% | RS | Trend | Market cap | P/E | PEG | ROE | P/B | D/E | EPS growth | F-score | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Health Care | $273.20 | up 3.6% | up 3.2% | up 47.8% | 2.5% | 78 | 8/8 | $852.3B | 31.8× | 0.35 | up 35% | 10.5× | 0.48 | down 96% | 4/9 | Low | |
| ISRG | Intuitive Surgical Inc | Health Care | $432.01 | down 4.5% | up 6.2% | down 18.5% | 3.0% | 40 | 2/8 | $153.4B | 53.7× | 2.36 | up 17% | 8.6× | — | down 24% | 7/9 | Low | |
| IQV | Iqvia Holdings Inc. | Health Care | $267.33 | down 4.3% | down 0.6% | up 23.5% | 3.4% | 83 | 8/8 | $45.3B | 33.3× | 7.09 | up 22% | 7.0× | 2.14 | up 9% | — | Moderate | |
| INCY | Incyte Corp | Health Care | $120.39 | up 4.0% | down 0.8% | up 30.0% | 3.1% | 72 | 7/8 | $23.9B | 18.6× | 0.00 | up 30% | 4.6× | — | down 283% | 8/9 | Low | |
| ILMN | Illumina, Inc. | Health Care | $235.99 | down 12.4% | down 13.8% | up 138.3% | 7.2% | 95 | 7/8 | $36.1B | 42.5× | — | up 33% | 13.3× | 0.55 | up 47% | 8/9 | Low | |
| IDXX | Idexx Laboratories Inc /De | Health Care | $551.21 | down 1.6% | up 5.6% | down 12.3% | 2.8% | 30 | 1/8 | $43.9B | 41.5× | 1.84 | up 66% | 27.4× | 0.23 | up 18% | 8/9 | Low | |
| HUM | Humana Inc | Health Care | $414.50 | down 1.6% | up 8.9% | up 46.7% | 3.5% | 93 | 8/8 | $82.4B | 69.3× | — | up 7% | 4.7× | 0.70 | — | — | Low | |
| HSIC | Henry Schein Inc | Health Care | $84.88 | down 0.1% | up 1.1% | up 34.9% | 2.2% | 66 | 6/8 | $9.8B | 23.5× | 2.23 | up 13% | 3.0× | 0.72 | up 17% | 6/9 | Low | |
| HCA | Hca Healthcare, Inc. | Health Care | $473.19 | up 0.9% | up 10.9% | up 1.9% | 3.1% | 59 | 4/8 | $106.3B | 15.7× | 0.54 | — | — | — | up 4% | — | Elevated | |
| GILD | Gilead Sciences, Inc. | Health Care | $170.68 | up 9.4% | up 14.5% | up 46.8% | 2.6% | 87 | 7/8 | $211.8B | 24.9× | 0.01 | up 40% | 9.3× | 0.97 | down 20% | 8/9 | Low | |
| GEHC | Ge Healthcare Technologies Inc. | Health Care | $76.57 | up 7.2% | up 17.2% | up 2.2% | 2.7% | 59 | 3/8 | $35.1B | 16.9× | 3.52 | up 22% | 3.4× | 0.91 | up 39% | 5/9 | Moderate | |
| EW | Edwards Lifesciences Corp | Health Care | $92.01 | up 3.3% | up 6.6% | up 10.2% | 2.4% | 59 | 6/8 | $53.4B | 49.8× | — | up 11% | 5.2× | 0.06 | down 26% | 5/9 | Low | |
| ELV | Elevance Health, Inc. | Health Care | $420.07 | down 4.5% | up 8.0% | up 32.5% | 2.8% | 73 | 8/8 | $92.7B | 16.4× | — | up 13% | 2.1× | 0.70 | up 18% | 7/9 | Low | |
| DXCM | Dexcom Inc | Health Care | $82.29 | up 5.6% | down 4.6% | up 20.7% | 3.2% | 65 | 6/8 | $31.7B | 37.9× | 0.79 | up 34% | 11.5× | — | up 3% | 8/9 | Low | |
| DVA | Davita Inc. | Health Care | $187.50 | up 2.1% | up 7.2% | up 57.9% | 3.9% | 78 | 6/8 | $12.9B | 11.9× | — | — | — | — | up 67% | — | Elevated | |
| DGX | Quest Diagnostics Inc | Health Care | $251.82 | up 4.1% | up 8.4% | up 45.2% | 2.5% | 82 | 8/8 | $40.8B | 41.1× | 2.96 | up 14% | 5.7× | 0.72 | up 28% | 6/9 | Low | |
| CRL | Charles River Laboratories International, Inc. | Health Care | $359.41 | up 4.1% | up 21.8% | up 100.7% | 3.9% | 97 | 8/8 | $17.7B | — | — | down 4% | 5.6× | 0.68 | down 103% | — | Moderate | |
| COR | Cencora, Inc. | Health Care | $330.84 | 0.0% | up 10.2% | down 2.3% | 2.2% | 50 | 5/8 | $64.2B | 41.3× | 7.29 | up 144% | 42.5× | 5.00 | up 12% | 7/9 | Elevated | |
| COO | Cooper Companies, Inc. | Health Care | $59.55 | down 2.7% | up 5.3% | down 15.1% | 2.7% | 17 | 0/8 | $11.7B | 31.1× | — | up 5% | 1.4× | 0.30 | up 355% | 5/9 | Low | |
| CNC | Centene Corp | Health Care | $68.45 | down 2.5% | up 10.2% | up 95.5% | 3.8% | 89 | 8/8 | $33.7B | — | — | down 29% | 1.7× | 0.87 | — | 5/9 | Elevated | |
| CI | Cigna Group | Health Care | $298.23 | down 2.8% | up 9.7% | up 23.4% | 2.5% | 55 | 6/8 | $78.6B | 13.2× | 0.16 | up 14% | 1.9× | 0.74 | up 10% | 7/9 | Moderate | |
| CAH | Cardinal Health Inc | Health Care | $250.48 | up 0.4% | up 12.8% | up 32.9% | 2.3% | 79 | 8/8 | $67.9B | 39.6× | 3.27 | — | — | — | — | 6/9 | Elevated | |
| BSX | Boston Scientific Corp | Health Care | $41.98 | down 8.1% | down 3.8% | down 58.3% | 3.6% | 7 | 0/8 | $73.3B | 25.3× | 0.45 | up 13% | 3.0× | 0.46 | up 15% | 8/9 | Low | |
| BMY | Bristol Myers Squibb Co | Health Care | $62.48 | up 1.6% | up 1.2% | up 41.6% | 2.8% | 69 | 7/8 | $181.2B | 25.7× | — | up 41% | 9.8× | 2.32 | down 2% | 9/9 | Moderate | |
| BIIB | Biogen Inc. | Health Care | $253.62 | up 1.2% | up 12.3% | up 69.5% | 3.1% | 90 | 8/8 | $37.2B | 28.8× | — | up 7% | 2.0× | 0.34 | down 104% | 4/9 | Low |